Prof. Dr. Michael Rossbach (*1978), is a seasoned life and health sciences professional, with expertise in diagnostics, cell-based therapeutics, neuroscience and genomics. Michael holds academic appointments at the National University of Singapore (NUS), at the German Institute of Science and Technology (TUM Asia) in Singapore (Biochemistry, Cell biology, and Bioorganic Chemistry), at INSEAD Management School (Entrepreneur-in- Residence) and he is Prof. and a member of the Faculty of the Witten School of Management (Germany). Since 2016, Michael is the VP Global Pharma Partnering of Vela Diagnostics (Singapore/Germany/USA) and focuses on the development of companion diagnostics (NGS and qPCR-based) to advance precision medicine.
Prior to joining Vela Diagnostics, Michael served as the Director for Strategic Alliances & Scientific Program Management of the Genome Institute of Singapore (GIS) for five years. Before the GIS appointment, he was a group leader at the Institute of Reconstructive Neurobiology, University of Bonn (Germany), and the Business Development Manager of LIFE&BRAIN.
Michael is the Principal of Roßbach & Company (Advisors in Health and Life Sciences), Associate of the Biotech Developpement Conseils in Paris, and Partner of Ryan-Kay Sarl in Switzerland and serves on the Advisory Board of several biotech companies. Michael studied biochemistry (PhD in immunology) at the University of New South Wales (Sydney, Australia), at the University of Witten/Herdecke (Witten, Germany) and at Harvard Medical School (Boston, USA).